Cannabis Bioscience International Holdings (CBIH) Equity Average (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Equity Average across 4 years of filings, most recently posting -$1.4 million for Q1 2026.

• Equity Average for Q1 2026 came in at -$1.4 million, down 19.91% year-over-year; the trailing twelve-month figure through Feb 2026 was -$1.4 million (down 19.91% YoY), and the FY2025 annual result was -$1.1 million, down 34.23% from the prior year.
• Equity Average came in at -$1.4 million for Q1 2026 at Cannabis Bioscience International Holdings, down from -$1.3 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of -$443479.5 in Q1 2023 to a low of -$1.4 million in Q1 2026.
• The 4-year median for Equity Average is -$1.1 million (2024), against an average of -$985595.0.
• Across the five-year window, Equity Average tumbled 104.97% in 2024 and fell 12.91% in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Equity Average stood at -$779673.0 in 2023, then plunged by 40.45% to -$1.1 million in 2024, then dropped by 19.14% to -$1.3 million in 2025, then decreased by 8.47% to -$1.4 million in 2026.
• The last three Equity Average figures came in at -$1.4 million (Q1 2026), -$1.3 million (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.